Lead immunotherapy research planning in cancer, infectious and autoimmune diseases; evaluate AI-derived findings, analyze data, prepare scientific materials, and support technical due diligence.
About this role
This role sits in NEC’s AI Drug Development Division and its Translational Research team, applying life-science expertise to AI-based drug discovery for pharmaceutical and research partners. The work focuses on immunotherapy and clinical application in cancer, infectious diseases, and autoimmune diseases.
The researcher leads clinical research plans, evaluates the biological validity and clinical applicability of AI-generated insights, and designs or conducts validation experiments when needed. Responsibilities also include data analysis and reporting, technical due diligence of external technologies, and preparation of scientific overviews, executive summaries, data visualizations, and technical documents for business development. The posting identifies bioinformatics, cell and animal experiments, proteomics, mass spectrometry, and drug-development regulatory processes as relevant areas.
Applicants must hold a Ph.D. in fields such as immunology, virology, or oncology and have at least two years of pharma or biotech experience in a matrixed international environment.
This is an AI-generated summary of the employer's original posting — details can be incomplete, out of date or simply wrong. Always confirm everything on the official posting before applying.